Skip to main content
Erschienen in: Diabetologia 7/2013

01.07.2013 | Article

Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry

verfasst von: H. U. Irgens, J. Molnes, B. B. Johansson, M. Ringdal, T. Skrivarhaug, D. E. Undlien, O. Søvik, G. Joner, A. Molven, P. R. Njølstad

Erschienen in: Diabetologia | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Monogenic diabetes (MD) might be misdiagnosed as type 1 diabetes. The prevalence of MD among children with apparent type 1 diabetes has not been established. Our aim was to estimate the prevalence of common forms of MD in childhood diabetes.

Methods

We investigated 2,756 children aged 0–14 years with newly diagnosed diabetes who had been recruited to the nationwide population-based Norwegian Childhood Diabetes Registry (NCDR), from July 2002 to March 2012. Completeness of ascertainment was 91%. Children diagnosed with diabetes who were under12 months of age were screened for mutations in KCNJ11, ABCC8 and INS. Children without GAD and protein tyrosine phosphatase-like protein antibodies were screened in two ways. Those who had a parent with diabetes were screened for mutations in HNF1A, HNF4A, INS and MT-TL1. Children with HbA1c <7.5% (<58 mmol/mol) and no insulin requirement were screened for mutations in GCK. Finally, we searched the Norwegian MODY Registry for children with genetically verified MD.

Results

We identified 15 children harbouring a mutation in HNF1A, nine with one in GCK, four with one in KCNJ11, one child with a mutation in INS and none with a mutation in MT-TL1. The minimum prevalence of MD in the NCDR was therefore 1.1%. By searching the Norwegian MODY Registry, we found 24 children with glucokinase-MODY, 15 of whom were not present in the NCDR. We estimated the minimum prevalence of MD among Norwegian children to be 3.1/100,000.

Conclusions/interpretation

This is the first prevalence study of the common forms of MD in a nationwide, population-based registry of childhood diabetes. We found that 1.1% of patients in the Norwegian Childhood Diabetes Registry had MD.
Literatur
1.
Zurück zum Zitat Molven A, Njolstad PR (2011) Role of molecular genetics in transforming diagnosis of diabetes mellitus. Expert Rev Mol Diagn 11:313–320PubMed Molven A, Njolstad PR (2011) Role of molecular genetics in transforming diagnosis of diabetes mellitus. Expert Rev Mol Diagn 11:313–320PubMed
2.
Zurück zum Zitat Vaxillaire M, Bonnefond A, Froguel P (2012) The lessons of early-onset monogenic diabetes for the understanding of diabetes pathogenesis. Best Pract Res Clin Endocrinol Metab 26:171–187PubMedCrossRef Vaxillaire M, Bonnefond A, Froguel P (2012) The lessons of early-onset monogenic diabetes for the understanding of diabetes pathogenesis. Best Pract Res Clin Endocrinol Metab 26:171–187PubMedCrossRef
3.
Zurück zum Zitat Gloyn AL, Pearson ER, Antcliff JF et al (2004) Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350:1838–1849PubMedCrossRef Gloyn AL, Pearson ER, Antcliff JF et al (2004) Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350:1838–1849PubMedCrossRef
4.
Zurück zum Zitat Babenko AP, Polak M, Cave H et al (2006) Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 355:456–466PubMedCrossRef Babenko AP, Polak M, Cave H et al (2006) Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 355:456–466PubMedCrossRef
5.
Zurück zum Zitat Stoy J, Steiner DF, Park SY, Ye H, Philipson LH, Bell GI (2010) Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene. Rev Endocr Metab Disord 11:205–215PubMedCrossRef Stoy J, Steiner DF, Park SY, Ye H, Philipson LH, Bell GI (2010) Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene. Rev Endocr Metab Disord 11:205–215PubMedCrossRef
6.
Zurück zum Zitat Habeb AM, Flanagan SE, Deeb A et al (2012) Permanent neonatal diabetes: different aetiology in Arabs compared to Europeans. Arch Dis Child 97:721–723PubMedCrossRef Habeb AM, Flanagan SE, Deeb A et al (2012) Permanent neonatal diabetes: different aetiology in Arabs compared to Europeans. Arch Dis Child 97:721–723PubMedCrossRef
7.
Zurück zum Zitat Bonnefond A, Philippe J, Durand E et al (2012) Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene. PLoS One 7:e37423PubMedCrossRef Bonnefond A, Philippe J, Durand E et al (2012) Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene. PLoS One 7:e37423PubMedCrossRef
8.
Zurück zum Zitat Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S (2010) Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53:2504–2508PubMedCrossRef Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S (2010) Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53:2504–2508PubMedCrossRef
9.
Zurück zum Zitat Estalella I, Rica I, Perez de Nanclares G et al (2007) Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain. Clin Endocrinol 67:538–546 Estalella I, Rica I, Perez de Nanclares G et al (2007) Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain. Clin Endocrinol 67:538–546
10.
Zurück zum Zitat Schober E, Rami B, Grabert M et al (2009) Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database. Diabet Med J Br Diabet Assoc 26:466–473CrossRef Schober E, Rami B, Grabert M et al (2009) Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database. Diabet Med J Br Diabet Assoc 26:466–473CrossRef
11.
Zurück zum Zitat Page RC, Hattersley AT, Levy JC et al (1995) Clinical characteristics of subjects with a missense mutation in glucokinase. Diabet Med J Br Diabet Assoc 12:209–217CrossRef Page RC, Hattersley AT, Levy JC et al (1995) Clinical characteristics of subjects with a missense mutation in glucokinase. Diabet Med J Br Diabet Assoc 12:209–217CrossRef
12.
Zurück zum Zitat Shepherd M, Shields B, Ellard S, Rubio-Cabezas O, Hattersley AT (2009) A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients. Diabet Med J Br Diabet Assoc 26:437–441CrossRef Shepherd M, Shields B, Ellard S, Rubio-Cabezas O, Hattersley AT (2009) A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients. Diabet Med J Br Diabet Assoc 26:437–441CrossRef
13.
Zurück zum Zitat Isomaa B, Henricsson M, Lehto M et al (1998) Chronic diabetic complications in patients with MODY3 diabetes. Diabetologia 41:467–473PubMedCrossRef Isomaa B, Henricsson M, Lehto M et al (1998) Chronic diabetic complications in patients with MODY3 diabetes. Diabetologia 41:467–473PubMedCrossRef
14.
Zurück zum Zitat Bellanne-Chantelot C, Chauveau D, Gautier JF et al (2004) Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann Intern Med 140:510–517PubMedCrossRef Bellanne-Chantelot C, Chauveau D, Gautier JF et al (2004) Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann Intern Med 140:510–517PubMedCrossRef
15.
Zurück zum Zitat Oram RA, Edghill EL, Blackman J et al (2010) Mutations in the hepatocyte nuclear factor-1β (HNF1B) gene are common with combined uterine and renal malformations but are not found with isolated uterine malformations. Am J Obstet Gynecol 203(364):e1–e5PubMed Oram RA, Edghill EL, Blackman J et al (2010) Mutations in the hepatocyte nuclear factor-1β (HNF1B) gene are common with combined uterine and renal malformations but are not found with isolated uterine malformations. Am J Obstet Gynecol 203(364):e1–e5PubMed
16.
Zurück zum Zitat Raeder H, Johansson S, Holm PI et al (2006) Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet 38:54–62PubMedCrossRef Raeder H, Johansson S, Holm PI et al (2006) Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet 38:54–62PubMedCrossRef
17.
Zurück zum Zitat Haldorsen IS, Raeder H, Vesterhus M, Molven A, Njolstad PR (2012) The role of pancreatic imaging in monogenic diabetes mellitus. Nat Rev Endocrinol 8:148–159CrossRef Haldorsen IS, Raeder H, Vesterhus M, Molven A, Njolstad PR (2012) The role of pancreatic imaging in monogenic diabetes mellitus. Nat Rev Endocrinol 8:148–159CrossRef
18.
Zurück zum Zitat Murphy R, Turnbull DM, Walker M, Hattersley AT (2008) Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet Med J Br Diabet Assoc 25:383–399CrossRef Murphy R, Turnbull DM, Walker M, Hattersley AT (2008) Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet Med J Br Diabet Assoc 25:383–399CrossRef
19.
Zurück zum Zitat Tsukuda K, Suzuki Y, Kameoka K et al (1997) Screening of patients with maternally transmitted diabetes for mitochondrial gene mutations in the tRNA[Leu(UUR)] region. Diabet Med J Br Diabet Assoc 14:1032–1037CrossRef Tsukuda K, Suzuki Y, Kameoka K et al (1997) Screening of patients with maternally transmitted diabetes for mitochondrial gene mutations in the tRNA[Leu(UUR)] region. Diabet Med J Br Diabet Assoc 14:1032–1037CrossRef
20.
Zurück zum Zitat Iafusco D, Massa O, Pasquino B et al (2012) Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births. Acta Diabetol 49:405–408PubMedCrossRef Iafusco D, Massa O, Pasquino B et al (2012) Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births. Acta Diabetol 49:405–408PubMedCrossRef
21.
Zurück zum Zitat Stanik J, Gasperikova D, Paskova M et al (2007) Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers. J Clin Endocrinol Metab 92:1276–1282PubMedCrossRef Stanik J, Gasperikova D, Paskova M et al (2007) Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers. J Clin Endocrinol Metab 92:1276–1282PubMedCrossRef
22.
Zurück zum Zitat Slingerland AS, Shields BM, Flanagan SE et al (2009) Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births. Diabetologia 52:1683–1685PubMedCrossRef Slingerland AS, Shields BM, Flanagan SE et al (2009) Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births. Diabetologia 52:1683–1685PubMedCrossRef
23.
Zurück zum Zitat Shankar RK, Pihoker C, Dolan LM et al (2012) Permanent neonatal diabetes mellitus: prevalence and genetic diagnosis in the SEARCH for Diabetes in Youth Study. Pediatr Diabetes. doi:10.1111/pedi.12003 Shankar RK, Pihoker C, Dolan LM et al (2012) Permanent neonatal diabetes mellitus: prevalence and genetic diagnosis in the SEARCH for Diabetes in Youth Study. Pediatr Diabetes. doi:10.​1111/​pedi.​12003
24.
Zurück zum Zitat Wiedemann B, Schober E, Waldhoer T et al (2010) Incidence of neonatal diabetes in Austria—calculation based on the Austrian Diabetes Register. Pediatr Diabetes 11:18–23PubMedCrossRef Wiedemann B, Schober E, Waldhoer T et al (2010) Incidence of neonatal diabetes in Austria—calculation based on the Austrian Diabetes Register. Pediatr Diabetes 11:18–23PubMedCrossRef
25.
Zurück zum Zitat Eide SA, Raeder H, Johansson S et al (2008) Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study). Diabet Med J Br Diabet Assoc 25:775–781CrossRef Eide SA, Raeder H, Johansson S et al (2008) Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study). Diabet Med J Br Diabet Assoc 25:775–781CrossRef
26.
Zurück zum Zitat Kropff J, Selwood MP, McCarthy MI, Farmer AJ, Owen KR (2011) Prevalence of monogenic diabetes in young adults: a community-based, cross-sectional study in Oxfordshire, UK. Diabetologia 54:1261–1263PubMedCrossRef Kropff J, Selwood MP, McCarthy MI, Farmer AJ, Owen KR (2011) Prevalence of monogenic diabetes in young adults: a community-based, cross-sectional study in Oxfordshire, UK. Diabetologia 54:1261–1263PubMedCrossRef
27.
Zurück zum Zitat Fendler W, Borowiec M, Baranowska-Jazwiecka A et al (2012) Prevalence of monogenic diabetes amongst Polish children after a nationwide genetic screening campaign. Diabetologia 55:2631–2635PubMedCrossRef Fendler W, Borowiec M, Baranowska-Jazwiecka A et al (2012) Prevalence of monogenic diabetes amongst Polish children after a nationwide genetic screening campaign. Diabetologia 55:2631–2635PubMedCrossRef
28.
Zurück zum Zitat Sagen JV, Raeder H, Hathout E et al (2004) Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 53:2713–2718PubMedCrossRef Sagen JV, Raeder H, Hathout E et al (2004) Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 53:2713–2718PubMedCrossRef
29.
Zurück zum Zitat Pearson ER, Flechtner I, Njolstad PR et al (2006) Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355:467–477PubMedCrossRef Pearson ER, Flechtner I, Njolstad PR et al (2006) Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355:467–477PubMedCrossRef
30.
Zurück zum Zitat Garin I, Perez de Nanclares G, Gastaldo E, Harries LW, Rubio-Cabezas O, Castano L (2012) Permanent neonatal diabetes caused by creation of an ectopic splice site within the INS gene. PLoS One 7:e29205PubMedCrossRef Garin I, Perez de Nanclares G, Gastaldo E, Harries LW, Rubio-Cabezas O, Castano L (2012) Permanent neonatal diabetes caused by creation of an ectopic splice site within the INS gene. PLoS One 7:e29205PubMedCrossRef
31.
Zurück zum Zitat Sandal T, Laborie LB, Brusgaard K et al (2009) The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy. Clin Genet 75:440–448PubMedCrossRef Sandal T, Laborie LB, Brusgaard K et al (2009) The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy. Clin Genet 75:440–448PubMedCrossRef
32.
Zurück zum Zitat Carette C, Dubois-Laforgue D, Saint-Martin C et al (2010) Familial young-onset forms of diabetes related to HNF4A and rare HNF1A molecular aetiologies. Diabet Med J Br Diabet Assoc 27:1454–1458CrossRef Carette C, Dubois-Laforgue D, Saint-Martin C et al (2010) Familial young-onset forms of diabetes related to HNF4A and rare HNF1A molecular aetiologies. Diabet Med J Br Diabet Assoc 27:1454–1458CrossRef
33.
Zurück zum Zitat Schlosser M, Strebelow M, Wassmuth R et al (2002) The Karlsburg type 1 diabetes risk study of a normal schoolchild population: association of beta-cell autoantibodies and human leukocyte antigen-DQB1 alleles in antibody-positive individuals. J Clin Endocrinol Metab 87:2254–2261PubMedCrossRef Schlosser M, Strebelow M, Wassmuth R et al (2002) The Karlsburg type 1 diabetes risk study of a normal schoolchild population: association of beta-cell autoantibodies and human leukocyte antigen-DQB1 alleles in antibody-positive individuals. J Clin Endocrinol Metab 87:2254–2261PubMedCrossRef
34.
Zurück zum Zitat Johansson S, Irgens H, Chudasama KK et al (2012) Exome sequencing and genetic testing for MODY. PLoS One 7:e38050PubMedCrossRef Johansson S, Irgens H, Chudasama KK et al (2012) Exome sequencing and genetic testing for MODY. PLoS One 7:e38050PubMedCrossRef
Metadaten
Titel
Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry
verfasst von
H. U. Irgens
J. Molnes
B. B. Johansson
M. Ringdal
T. Skrivarhaug
D. E. Undlien
O. Søvik
G. Joner
A. Molven
P. R. Njølstad
Publikationsdatum
01.07.2013
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 7/2013
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-2916-y

Weitere Artikel der Ausgabe 7/2013

Diabetologia 7/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.